Fresh analysis indicates that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who end conventional lifestyle regimens.
Published data in a prominent medical journal points out that while obese individuals can lose about a fifth of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing these medications need to be aware of the danger of fast weight regain when the medication ends," stated researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment weight in about a year and a half.
Weighing Treatments
The study, which reviewed dozens of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
The team note that people who shed pounds through diet and exercise usually experience a less rapid weight regain—perhaps 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Nutrition scientists believe the mechanism of the jabs explains the amplified weight return.
The injections imitate a natural hormone called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone levels far above than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means appetite is no longer kept in check, making overeating a significant risk."
An Ongoing Disease?
The NHS advise the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals argue that, considering the likelihood of weight regain, the treatment might need to be life-long.
This perspective is echoed by pharmaceutical companies, who note that the results "underscore the chronic character of excess weight," similar to managing diseases like high blood pressure.
User Accounts
Users who have discontinued the jabs explain a sudden resurgence of appetite.
"I experienced a trigger that goes on and you're instantly starving," recalled a patient.
This challenge is worsened if patients have not developed sustainable lifestyle or habit modifications during therapy.
Significant Use
Recent estimates show that a significant number of people in the UK have tried these injections in the past year, with interest remaining high.
- Use is more common among females than men.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
Ultimately, researchers caution that while these medications are powerful tools for weight loss, they are not a permanent solution and long-term success likely depends on ongoing lifestyle support.
